RMTI Stock Analysis: Buy, Sell, or Hold?
RMTI - Rockwell Medical, Inc. (DE) Common Stock
$5.63
-0.04 (-0.71%)
▼
5d:
-7.7%
30d:
+804.27%
90d:
+499.0%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
28d
Get Alerted When RMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: RMTI is 16.3% above its trading range ($4.84). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: RMTI is 16.3% above its trading range ($4.84). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: RMTI is currently trading at $5.63, which is considered extended relative to its 30-day fair value range of $0.04 to $4.84. From a valuation perspective, the stock is trading at a discount (Forward PE: -66.2) compared to its historical average (17.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RMTI is in a strong downtrend. The price is approaching resistance at $0.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RMTI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+432.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RMTI is in a strong downtrend. The price is approaching resistance at $0.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RMTI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+432.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.04 -
$4.84
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price significantly overextended (+16.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 432.9% below Wall St target ($30.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to 16.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.04 -
$4.84
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.64
Resistance Level
$0.79
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-66.24
Wall Street Target
$30.00
(+432.9%)
Revenue Growth (YoY)
-8.3%
Profit Margin
-8.0%
PE vs Historical
-66.2 vs 17.3
CHEAP
Share & Embed Analysis
Last updated: July 15, 2026 2:42 AM ET
Data refreshes hourly during market hours. Next update: 3:42 AM
Data refreshes hourly during market hours. Next update: 3:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 54 HOLD |
